Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov enrollment closed early-phase tilt small index

Skin Carcinoma: early-phase trial registry

A small indexed set (5 trials) with no open enrollment listed right now.

Corpus placement: #3,391 of 28,707 conditions by registered trial count.

5 US clinical trials · none currently recruiting · #3,391 of 28,707 conditions by registered trial count

Skin Carcinoma: 5 US clinical trials tracked, none currently recruiting.

Skin Carcinoma is the subject of 5 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Fox Chase Cancer Center, running 1 of these trials.

Enrollment posture brief

Registry condition skin-carcinoma

OPEN 0 | RECR 0% | LATE 0 | EARLY 1 | RANK #3391 | SPON 1

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Skin Carcinoma (this)0%
Open-enrollment share among volume-matched conditions near Skin Carcinoma

Skin Carcinoma has no open enrollment in this registry pull (5 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Skin Carcinoma on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Skin Carcinoma is recruiting below its size-band peers.

    0 of 5 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Skin Carcinoma research.

    Fox Chase Cancer Center accounts for 1 of 5 trials (20%). 5 distinct sponsors appear on at least one study for this condition label.

  3. Typical Skin Carcinoma enrolment sits around 100 participants.

    Median target enrolment is 100 among the 5 trials that report a genuine target (sentinel values excluded). 2 of those (40%) plan for fewer than 100 participants.

  4. Skin Carcinoma research is mostly interventional.

    5 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 11

Phase Distribution

PhaseTrial count
Phase 1 1

Named interventions

Most-linked intervention names on Skin Carcinoma records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Questionnaire Administration Other
2 trials
Lavender essential oil Other
1 trials
Educational Intervention (Physician) Other
1 trials
Dermatoscope Device
1 trials
Computer-Assisted Intervention Other
1 trials
Compliance Monitoring Behavioral
1 trials
Dermoscopy Other
1 trials
Confocal Microscopy Other
1 trials

US sites by state

Facility locations filed on Skin Carcinoma trials. A trial with sites in several states counts in each.

Pennsylvania 1 trials
Oregon 1 trials
Ohio 1 trials
Florida 1 trials
California 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Skin Carcinoma page

5 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • No Skin Carcinoma trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Fox Chase Cancer Center sponsors the most Skin Carcinoma trials on record, review their full trial history before evaluating a specific study. See Fox Chase Cancer Center's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Skin Carcinoma condition card totals 5 registered trials; most-linked intervention Questionnaire Administration; top US site state Pennsylvania. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.